Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John G Gums

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
The Annals of Pharmacotherapy|November 25, 2003
Tezosentan in the treatment of acute heart failureJohn M Tovar, John G Gums
The Annals of Pharmacotherapy|September 2, 2004
The changing face of antibiotic prescribing: the mutant selection windowBenjamin J Epstein, John G Gums, Karl Drlica
Postgraduate Medicine|December 7, 2017
Infectious vaginitisMichelle A Goode, Ken Grauer, John G Gums
American Family Physician|December 26, 2006
Newer agents for the management of overactive bladderBenjamin J Epstein, John G Gums, Emerson Molina
The Annals of Pharmacotherapy|May 5, 2011
Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic diseaseJessica A Bovio, Steven M Smith, John G Gums
Expert Opinion on Pharmacotherapy|January 19, 2008
Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and childrenJohn G Gums, Elise M Pelletier, William A Blumentals
The Annals of Pharmacotherapy|March 1, 2019
Erenumab: A First-in-Class Monoclonal Antibody for Migraine PreventionScott G Garland, Steven M Smith, John G Gums
The Journal of Family Practice|December 5, 2017
The benefits of physician-pharmacist collaborationAndrew Y Hwang, Tyler H Gums, John G Gums
The Annals of Pharmacotherapy|January 18, 2022
Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and SchizophreniaChristie Monahan, Lindsey McCoy, Jason Powell, et al.
Drugs|November 22, 2014
Combining a GLP-1 receptor agonist and basal insulin: study evidence and practical considerationsNicholas W Carris, James R Taylor, John G Gums
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
The Annals of Pharmacotherapy|November 25, 2003
Tezosentan in the treatment of acute heart failureJohn M Tovar, John G Gums
The Annals of Pharmacotherapy|September 2, 2004
The changing face of antibiotic prescribing: the mutant selection windowBenjamin J Epstein, John G Gums, Karl Drlica
Postgraduate Medicine|December 7, 2017
Infectious vaginitisMichelle A Goode, Ken Grauer, John G Gums
American Family Physician|December 26, 2006
Newer agents for the management of overactive bladderBenjamin J Epstein, John G Gums, Emerson Molina
The Annals of Pharmacotherapy|May 5, 2011
Dabigatran etexilate: a novel oral thrombin inhibitor for thromboembolic diseaseJessica A Bovio, Steven M Smith, John G Gums
Expert Opinion on Pharmacotherapy|January 19, 2008
Oseltamivir and influenza-related complications, hospitalization and healthcare expenditure in healthy adults and childrenJohn G Gums, Elise M Pelletier, William A Blumentals
The Annals of Pharmacotherapy|March 1, 2019
Erenumab: A First-in-Class Monoclonal Antibody for Migraine PreventionScott G Garland, Steven M Smith, John G Gums
The Journal of Family Practice|December 5, 2017
The benefits of physician-pharmacist collaborationAndrew Y Hwang, Tyler H Gums, John G Gums
The Annals of Pharmacotherapy|January 18, 2022
Olanzapine/Samidorphan: New Drug Approved for Treating Bipolar I Disorder and SchizophreniaChristie Monahan, Lindsey McCoy, Jason Powell, et al.
Drugs|November 22, 2014
Combining a GLP-1 receptor agonist and basal insulin: study evidence and practical considerationsNicholas W Carris, James R Taylor, John G Gums
Pageof 10